Table 4 
National SARS-CoV-2 antibody seroprevalence estimates, by antibody seroprevalence type and visible minority status 

 Back to main article CSV (1 KB)
National SARS-CoV-2 antibody seroprevalence estimates, by antibody seroprevalence type and visible minority status
  Antibody seroprevalence overall percentage Low 95% Confidence Interval High 95% Confidence Interval Antibody seroprevalence due to infection percentage Low 95% Confidence Interval High 95% Confidence Interval Antibody seroprevalence due to vaccination percentage Low 95% Confidence Interval High 95% Confidence Interval
Visible Minority 4.8 3.1 6.8 4.3 2.6 6.3 0.5 0.0 1.2
Not a Visible Minority 3.3 2.3 3.9 2.1 1.1 2.6 1.2 0.2 1.5
Source(s):
Statistics Canada; Canadian COVID-19 Antibody and Health Survey (5339).
Date modified: